I was thinking... If somebody were to total up all the money spent on the medicines that the world uses now that could be replaced by Sativex, Epidiolex, and ALL the cannabinoid derivitives, it's gotta be around a jillion dollars a year. If GW Pharma doesn't have to sell the co. to Bayer, then we are going to be a co. with a market cap of $500 billion!!... plus or minus a billion or two. Just sayin'.
The best case scenario is GWP would have $5 billion in revenues. That's maybe 5 years from now. If it has a typical revenue multiple of 4 times, that would be a $20 billion market cap. Or 20 times what it is now. Sounds silly high, but it has happened before. But to reach the end of the rainbow, everything has to fall into place. Lots of potential pitfalls.